设为首页 加入收藏

TOP

IMBRUVICA(ibrutinib)tablets,IMBRUVICA(ibrutinib)capsules(三十)
2018-04-05 03:05:10 来源: 作者: 【 】 浏览:16422次 评论:0
roduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:57962-280
Route of Administration ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
Ingredient Name Basis of Strength Strength
IBRUTINIB (UNII: 1X70OSD4VX) (IBRUTINIB - UNII:1X70OSD4VX) IBRUTINIB 280 mg
PRODUCT CHARACTERISTICS
Color PURPLE Score no score
Shape OVAL (Oblong) Size 15mm
Flavor  Imprint Code ibr;280
Contains    
PACKAGING
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:57962-280-28 1 in 1 CARTON 02/16/2018 
1  28 in 1 BLISTER PACK; Type 0: Not a Combination Product  
MARKETING INFORMATION
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA210563 02/16/2018 
IMBRUVICA
ibrutinib tablet, film coated
PRODUCT INFORMATION
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:57962-420
Route of Administration ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
Ingredient Name Basis of Strength Strength
IBRUTINIB (UNII: 1X70OSD4VX) (IBRUTINIB - UNII:1X70OSD4VX) IBRUTINIB 420 mg
PRODUCT CHARACTERISTICS
Color GREEN (Yellow-green to green) Score no score
Shape OVAL (Oblong) Size 18mm
Flavor  Imprint Code ibr;420
Contains    
PACKAGING
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:57962-420-28 1 in 1 CARTON 02/16/2018 
1  28 in 1 BLISTER PACK; Type 0: Not a Combination Product  
MARKETING INFORMATION
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA210563 02/16/2018 
IMBRUVICA
ibrutinib tablet, film coated
PRODUCT INFORMATION
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:57962-560
Route of Administration ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
Ingredient Name Basis of Strength Strength
IBRUTINIB (UNII: 1X70OSD4VX) (IBRUTINIB - UNII:1X70OSD4VX) IBRUTINIB 560 mg
PRODUCT CHARACTERISTICS
Color YELLOW (Yellow to orange) Score no score
Shape OVAL (Oblong) Size 19mm
Flavor  Imprint Code ibr;560
Contains    
PACKAGING
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:57962-560-28 1 in 1 CARTON 02/16/2018 
1  28 in 1 BLISTER PACK; Type 0: Not a Combination Product  
MARKETING INFORMATION
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA210563 02/16/2018 
LABELER - PHARMACYCLICS LLC (079857498)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Pharmacyclics LLC  079857498 ANALYSIS(57962-140, 57962
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 27 28 29 30 31 下一页 尾页 30/31/31
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇AZILECT(rasagiline tablets) 下一篇OZURDEX(dexamethasone intravitr..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位